Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model
Moritz Beck‐Broichsitter(Philipps University of Marburg), Tobias Gessler(University of Giessen), Julia Gauss(Justus-Liebig-Universität Gießen), Werner Seeger(Justus-Liebig-Universität Gießen), Thomas Kissel(Helmholtz Zentrum München), Claudia B. Packhaeuser(Philipps University of Marburg), Kerstin Lahnstein(Justus-Liebig-Universität Gießen), Thomas Schmehl(Saarland University)
Cited by 115
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
|The Lancet|2002|771
Pulmonary Hypertension in Chronic Lung Diseases
|Journal of the American College of Cardiology|2013|683